YINGCHI TMS In RANZCP Congress

15-19 May 2022, RANZCP 2022 Congress, International Convention Centre (ICC), Darling Harbour, Sydney Australia.

The Royal Australian and New Zealand College of Psychiatrists (RANZCP) 2022 Congress will be held in Sydney from 15-19 May 2022, organised on the theme of ‘stronger bridges, safer harbours’, and the interlinked concepts of connection, inclusion and creativity. Yingchi Brain Ultimate rTMS exhibited at the RANZCP 2022 in Sydney from 15 to18 May 2022.

More information

Details

Sydney NSW, Australia

Shenzhen Yingchi Technology Co.,Ltd.

Associated Trend items

YINGCHI TMS | Welcome to visit us in MEDICA 2023

With over 5,000 exhibitors from 66 countries and more than 81,000 visitors from all over the world, MEDICA in Düsseldorf is one of the largest medical B2B trade fairs in the world.

As an old friend, YINGCHI will once again participate in MEDICA 2023. We are committed to allowing more people to obtain high-quality medical services, and always adheres to independent research and development and technological research.

More information

New research published using YINGCHI TMS

Chinese professional team published their latest research results in "PAIN", a leading journal in the field of pain. In the process of experiment, rTMS stimulation was performed by the YINGCHI FDA-approved M-100 Ultimate.

This study investigates the opioid peptide analgesic mechanism of prolonged continuous theta burst stimulation (pcTBS). The study was a randomized, double-blind, sham-controlled study to reveal whether the endogenous opioid system is involved in the analgesic effects induced by stimulation of the primary motor cortex (M1) and dorsal lateral prefrontal cortex (DLPFC) by i...

More information

YINGCHI M-Ultimate TMS is cleared by FDA for MDD treatment!

We are glad to announce that YINGCHI M-Ultimate transcranial magnetic stimulator has already gained FDA approval this September.

As YINGCHI TMS device gains wider adoption in the medical community, it is expected to play a crucial role in the ongoing battle against depression. This FDA clearance is a testament to YINGCHI’s commitment to developing innovative solutions for mental health challenges. We are dedicated to providing patients with access to safe, non-invasive, and effective treatments fo...

More information

Products associated

TMS + rTMS transcranial magnetic stimulator

M-series

TMS + rTMS transcranial magnetic stimulator

E-series

Compare

Remove all

Compare up to 10 products